Cancer Atlas · pilot coverage

Where evidence is indexed—and where review is still needed.

This prototype atlas shows the eight-country search scope. It does not display cancer burden, incidence, mortality, or biomarker prevalence.

How to read this atlas

The future default metric is verified indexed studies by cohort origin. Gray means insufficient indexed evidence, never zero cancer. Counts remain hidden until the literature run and scientific review are complete.

NGGHTGBJCIMLNEBF

Coverage view
Review pending

CountryMetricStatus
NG

Nigeria

Gulf of Guinea · Western Africa

Verified indexed studiesNot published
Protocol pending
GH

Ghana

Gulf of Guinea · Western Africa

Verified indexed studiesNot published
Protocol pending
TG

Togo

Gulf of Guinea · Western Africa

Verified indexed studiesNot published
Protocol pending
BJ

Benin

Gulf of Guinea · Western Africa

Verified indexed studiesNot published
Protocol pending
CI

Côte d’Ivoire

Gulf of Guinea · Western Africa

Verified indexed studiesNot published
Protocol pending
ML

Mali

Sahel · Western Africa

Verified indexed studiesNot published
Protocol pending
NE

Niger

Sahel · Western Africa

Verified indexed studiesNot published
Protocol pending
BF

Burkina Faso

Sahel · Western Africa

Verified indexed studiesNot published
Protocol pending

Accessible table alternative

Country is a cohort field, not a keyword shortcut.

The reviewer will record recruitment country and sample-origin country separately. “Nigerian” cannot be counted as Niger, and “Benin City” cannot be counted as the country Benin.

See screening rules